Matches in Wikidata for { <http://www.wikidata.org/entity/Q99369379> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q99369379 description "2020 թվականի սեպտեմբերի 12-ին հրատարակված գիտական հոդված" @default.
- Q99369379 description "article scientifique publié en 2020" @default.
- Q99369379 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99369379 description "scientific article published on 12 September 2020" @default.
- Q99369379 description "wetenschappelijk artikel" @default.
- Q99369379 description "наукова стаття, опублікована 12 вересня 2020" @default.
- Q99369379 name "Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)" @default.
- Q99369379 name "Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)" @default.
- Q99369379 type Item @default.
- Q99369379 label "Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)" @default.
- Q99369379 label "Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)" @default.
- Q99369379 prefLabel "Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)" @default.
- Q99369379 prefLabel "Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)" @default.
- Q99369379 P1433 Q99369379-FCF3D62C-0F4E-4D48-902E-1C39603C92EE @default.
- Q99369379 P1476 Q99369379-37AA809C-8808-4E24-97DC-236C9244E2F1 @default.
- Q99369379 P2093 Q99369379-4613E1E4-CF30-43B1-8D94-AE9BD025B92C @default.
- Q99369379 P2093 Q99369379-5E3DAAE3-5726-4087-8F04-CC63D8EE9CDD @default.
- Q99369379 P2093 Q99369379-736AF57F-A02E-4BC4-97DB-FDBE6DC7C2AE @default.
- Q99369379 P2093 Q99369379-C8A74F45-EF71-4411-A9B2-E72C1C9B07FF @default.
- Q99369379 P2093 Q99369379-D1EFB70B-9C2C-49E4-A82D-77947ED73A78 @default.
- Q99369379 P2093 Q99369379-D72DE1FF-670C-4FE3-97C3-13FF3DEAF2E6 @default.
- Q99369379 P31 Q99369379-72C37F9C-93A5-44C1-95D8-8AF9F251ACAE @default.
- Q99369379 P356 Q99369379-880BEC27-2AE1-45C0-A6A6-BFAEA8FC4343 @default.
- Q99369379 P577 Q99369379-156A37B9-8E55-40A6-AFE7-05AA1C1BAB22 @default.
- Q99369379 P698 Q99369379-641EDD84-9DB5-42CF-BF9D-97AF834822D8 @default.
- Q99369379 P356 S40264-020-00982-9 @default.
- Q99369379 P698 32918682 @default.
- Q99369379 P1433 Q15724462 @default.
- Q99369379 P1476 "Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)" @default.
- Q99369379 P2093 "Bernard Bégaud" @default.
- Q99369379 P2093 "Gaëlle Nachbaur" @default.
- Q99369379 P2093 "Hugo Arlegui" @default.
- Q99369379 P2093 "Kaatje Bollaerts" @default.
- Q99369379 P2093 "Nicolas Praet" @default.
- Q99369379 P2093 "Vincent Bauchau" @default.
- Q99369379 P31 Q13442814 @default.
- Q99369379 P356 "10.1007/S40264-020-00982-9" @default.
- Q99369379 P577 "2020-09-12T00:00:00Z" @default.
- Q99369379 P698 "32918682" @default.